ClinicalTrials.Veeva

Menu

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation (era-cryo)

T

Tongji University

Status

Not yet enrolling

Conditions

Atrial Fibrillation

Treatments

Device: cryoballoon ablation

Study type

Observational

Funder types

Other

Identifiers

NCT05492760
era-cryo

Details and patient eligibility

About

The recurrence of atrial fibrillation(AF) after pulmonary vein ablation with cryoballoon is conducted by many factors . The previous studies found larger left atrial and longer AF duration are tied to higher risk of AF recurrence. The characters of ablation procedure is also of critical importance to durable clinical success such as temperature features and time-to-isolation (TTI). The aim of our study is to develop an tool of recurrence risk evaluation with both pre-procedure and procedure factors.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with paroxysmal AF and accept cryoballoon ablation.

Exclusion criteria

  • left atrium (LA) diameter (anterior-to-posterior)>55mm on transthoracic echocardiography (TTE)
  • the presence of thrombus in the LA or left atrial appendage (LAA) on transesophageal echocardiography (TEE)
  • uncorrected heart failure (NYHA class III or IV),
  • concomitant moderate or severe valvular heart disease or bioprosthetic valve,
  • malignancy necessitating chemotherapy.

Trial design

600 participants in 1 patient group

ablation group
Treatment:
Device: cryoballoon ablation

Trial contacts and locations

0

Loading...

Central trial contact

Yawei Xu, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems